Our findings show the need to do studies comparing key mutations in thyroid cancer such as BRAF and RET between Filipinos and other Asian subgroups to see if they may explain differences in clinical characteristics of thyroid cancer. The gene discussed is RET; the disease is thyroid gland carcinoma.